---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-054315"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:39:52.738540+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# InMed special meeting lacks quorum for share issuance vote; appoints new auditor CBIZ

## Summary
- Special meeting on June 13, 2025 lacked quorum; ~60% of voted shares favored share issuance proposal but no vote held. Board evaluating next steps.
- Marcum resigned as auditor after acquisition by CBIZ; Board appointed CBIZ as independent auditor for FY2025. No disagreements; prior material weakness remediated.
- Company amended SEPA with Yorkville to allow suspension of registration statement during black-out periods, subject to restrictions similar to insider trading policies.

## SEC filing metadata
- accession: 0001213900-25-054315
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 4.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390025054315/0001213900-25-054315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390025054315/ea0245506-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-054315
- JSON: https://secwatch.observer/filing/0001213900-25-054315.json
- Plain text: https://secwatch.observer/filing/0001213900-25-054315.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.